These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23109482)

  • 1. Tamiflu: the battle for secret drug data.
    Payne D
    BMJ; 2012 Oct; 345():e7303. PubMed ID: 23109482
    [No Abstract]   [Full Text] [Related]  

  • 2. Roche offers researchers access to all Tamiflu trials.
    Cohen D
    BMJ; 2013 Apr; 346():f2157. PubMed ID: 23558407
    [No Abstract]   [Full Text] [Related]  

  • 3. Questions remain over safety and effectiveness of oseltamivir.
    Cohen D
    BMJ; 2012 Jan; 344():e467. PubMed ID: 22252042
    [No Abstract]   [Full Text] [Related]  

  • 4. Roche says it will not relinquish control over access to clinical trial data.
    Kmietowicz Z
    BMJ; 2013 Feb; 346():f1374. PubMed ID: 23449695
    [No Abstract]   [Full Text] [Related]  

  • 5. The truth about Tamiflu? Data access is matter of trust.
    Maryon-Davis AR
    BMJ; 2010 Jan; 340():c134. PubMed ID: 20071427
    [No Abstract]   [Full Text] [Related]  

  • 6. Roche continues to drag its feet on access to Tamiflu data.
    Gøtzsche PC
    BMJ; 2013 May; 346():f3001. PubMed ID: 23678077
    [No Abstract]   [Full Text] [Related]  

  • 7. Search for evidence goes on.
    Cohen D
    BMJ; 2012 Jan; 344():e458. PubMed ID: 22252041
    [No Abstract]   [Full Text] [Related]  

  • 8. The Tamiflu tug of war.
    Schwartz ND
    Fortune; 2005 Nov; 152(10):33-4. PubMed ID: 16300366
    [No Abstract]   [Full Text] [Related]  

  • 9. We are asking more questions about NICE appraisal of Tamiflu.
    Rawlins M
    BMJ; 2012 Dec; 345():e8420. PubMed ID: 23236048
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tamiflu: 300 million treatments will be produced in the next few months].
    Nau JY
    Rev Med Suisse; 2005 Nov; 1(41):2697. PubMed ID: 16355888
    [No Abstract]   [Full Text] [Related]  

  • 11. Withdraw approval for Tamiflu until NICE has full data.
    Godlee F
    BMJ; 2012 Dec; 345():e8415. PubMed ID: 23236047
    [No Abstract]   [Full Text] [Related]  

  • 12. Open letter to Roche about oseltamivir trial data.
    Godlee F
    BMJ; 2012 Oct; 345():e7305. PubMed ID: 23109484
    [No Abstract]   [Full Text] [Related]  

  • 13. Desorption electrospray ionization reactions between host crown ethers and the influenza neuraminidase inhibitor oseltamivir for the rapid screening of Tamiflu.
    Nyadong L; Hohenstein EG; Johnson K; Sherrill CD; Green MD; Fernández FM
    Analyst; 2008 Nov; 133(11):1513-22. PubMed ID: 18936828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Companies face ethical issues over Tamiflu.
    Prystay C; Hiebert M; Linebaugh K
    Wall St J (East Ed); 2006 Jan; ():B1, B3. PubMed ID: 16502545
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficient access to oseltamivir phosphate (Tamiflu) via the O-trimesylate of shikimic acid ethyl ester.
    Karpf M; Trussardi R
    Angew Chem Int Ed Engl; 2009; 48(31):5760-2. PubMed ID: 19565588
    [No Abstract]   [Full Text] [Related]  

  • 16. Mixture toxicity of the antiviral drug Tamiflu((R)) (oseltamivir ethylester) and its active metabolite oseltamivir acid.
    Escher BI; Bramaz N; Lienert J; Neuwoehner J; Straub JO
    Aquat Toxicol; 2010 Feb; 96(3):194-202. PubMed ID: 19939473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roche Canada stops distributing oseltamivir.
    Spurgeon D
    BMJ; 2005 Nov; 331(7524):1041. PubMed ID: 16269478
    [No Abstract]   [Full Text] [Related]  

  • 18. Is oseltamivir (Tamiflu) safe? Re-examining the Tamiflu 'ado' from Japan.
    Okamoto E
    Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):17-24. PubMed ID: 20121561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indian firm to produce oseltamivir for developing countries.
    Mudur G
    BMJ; 2006 Jan; 332(7532):5. PubMed ID: 16399711
    [No Abstract]   [Full Text] [Related]  

  • 20. Development and validation of a rapid HPLC method for the determination of oseltamivir phosphate in Tamiflu and generic versions.
    Joseph-Charles J; Geneste C; Laborde-Kummer E; Gheyouche R; Boudis H; Dubost JP
    J Pharm Biomed Anal; 2007 Aug; 44(4):1008-13. PubMed ID: 17512688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.